Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Regeneron Pharmaceuticals Inc. buy Traumtanz

Start price
€503.80
28.04.20 / 50%
Target price
€550.00
29.04.20
Performance (%)
-5.84%
End price
€474.40
29.04.20
Summary
This prediction ended on 29.04.20 with a price of €474.40. With a performance of -5.84%, the BUY prediction for Regeneron Pharmaceuticals Inc. by Traumtanz closed slightly in the red. Traumtanz has 50% into this prediction

Regeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.

Performance without dividends (%)
Name 1w 1m 1y 3y
Regeneron Pharmaceuticals Inc. -0.280% -0.280% 16.787% 120.312%
iShares Core DAX® 1.883% 5.122% 21.667% 22.437%
iShares Nasdaq 100 0.125% 2.574% 45.951% 55.507%
iShares Nikkei 225® -0.201% 4.341% 28.806% 9.945%
iShares S&P 500 0.728% 4.141% 34.630% 50.086%

According to Traumtanz what are the pros and cons of Regeneron Pharmaceuticals Inc. for the foreseeable future?

Pros
Known brand
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Top 10 in its market
Revenue growth >5% per year expected
Standard Investments for future growth
Cons

Comments by Traumtanz for this prediction

In the thread Regeneron Pharmaceuticals Inc. diskutieren
Prediction Buy
Perf. (%) -5.84%
Target price 550.000
Change
Ends at 29.04.20

Buy mit Kursziel 550,0

In the thread Trading Regeneron Pharmaceuticals Inc.
Prediction Buy
Perf. (%) -5.84%
Target price 550.000
Change
Ends at 29.04.20

Buy beendet

Stopped prediction by Traumtanz for Regeneron Pharmaceuticals Inc.

buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€395.05
12.12.20
-
12.12.21
4.78%
09.01.21

Known brand
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Top 10 in its market
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€392.75
11.12.20
€250.00
0.97%
11.12.20

Known brand
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Top 10 in its market
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€529.00
22.11.20
€450.00
-25.76%
11.12.20

Known brand
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Top 10 in its market
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€514.00
03.10.20
€600.00
15.10.20
-1.81%
15.10.20

Known brand
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Top 10 in its market
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€470.45
04.04.20
-
18.04.20
13.70%
18.04.20

Known brand
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Top 10 in its market
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€400.05
22.03.20
€500.00
04.04.20
14.32%
04.04.20

Known brand
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Top 10 in its market
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€456.60
19.03.20
€500.00
20.03.20
-6.61%
20.03.20

Known brand
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Top 10 in its market
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€413.60
10.03.20
-
16.03.20
-4.06%
16.03.20

Known brand
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Top 10 in its market
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€407.45
07.03.20
€450.00
10.03.20
1.51%
10.03.20

Known brand
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Top 10 in its market